journal logo
  • search
  • open the menu

Intro Pullout Text Widget

RMD Open

is an open access, peer-reviewed rheumatology journal from BMJ and EULAR, publishing original research on rheumatic and musculoskeletal disorders and connective tissue diseases

Impact Factor: 5.117
Citescore: 6.1
All metrics >>

RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.

It is an online only open access journal that aims to provide rapid publication of research through a continuous publication model. All submitted content is subject to peer review prior to publication. Published work is free to read.

RMD Open is an official journal of EULAR.

Podcast icon Listen to the ARD and RMD Open podcast and subscribe in all podcast platforms, including Apple Podcasts, Google Podcasts and Spotify.

You can keep up with the latest news via Twitter and Facebook.

Editor-in-Chief: Professor Bernard Combe, CHU Lapeyronie, France
Editorial team

 

Current Issue
RMD Open

VACANCY: Editor-in-Chief

BMJ and EULAR are looking for the next Editor-in-Chief who can continue to shape RMD Open into the premier open access journal for rheumatology, maintaining the journal's high quality standards.

 

Specialists in any branch of rheumatology and musculoskeletal disorders are welcome to apply and international and joint applications are welcomed.

 

Application deadline: 31st August 2021

 

 

Why submit to RMD Open?

RMD Open

The leading open-access journal in rheumatic and musculoskeletal diseases and an official journal of EULAR.

RMD Open achieves first Journal Impact Factor

We are delighted to announce that RMD Open has just achieved its first Journal Impact Factor™ of 5.117. RMD Open has a CiteScore of 6.1 and is also indexed by MEDLINE.

 

Thank you to our authors, reviewers and editorial team members for their continued support in publishing high quality and high impact articles in the journal since its launch in 2015. You can access the top cited articles from 2019 and 2020.